By far the most frequent argument I encounter against the wisdom of curing aging is that it would cause unacceptable global overpopulation. While most other potential drawbacks of indefinite lifespans are generally acknowledged to be speculative, this one is robustly asserted to be inevitable, short of a compulsory sterilisation policy of unprecedented proportions. I therefore feel that it is w...

The purpose of this study is to investigate the factors affecting the evaluation of the quality of voluntary disclosure, given that the factors used in internal research due to having an external source and focusing on the number of disclosures may not be an appropriate criterion for measuring the quality of information disclosure, so, it is necessary to provide new influencing factors on the e...

Family networks are widely assumed to be a key source of support for older people in Indonesia and Southeast Asia more generally, although empirical study of their composition and functioning is in its infancy. This paper draws on ethnographic and survey data collected in longitudinal research of ageing in three rural Indonesian communities, in order to identify demographic and social factors l...

This paper presents a model in which some consumers shop on the basis of price alone, without attention to product quality. A firm may “cheat” (i.e., cut quality) to exploit these inattentive consumers. In the unique symmetric equilibrium, firms follow a mixed strategy involving both price and quality dispersion. Firms are less likely to cheat when there are fewer inattentive consumers, which i...

Using 1988 and 1991 data from nonprofit voluntary hospitals in California, we find that the vast majority of nonprofit hospitals provide community dividends in excess of the tax subsidies they receive. However, nearly 20 percent of nonprofit hospitals do not meet this standard. Further, those hospitals that do not meet the standard tend to not meet the standard over time. We recommend more expl...

1,2JESSICA E SCAIFE, MSc, FRCR, 1,3SIMON J THOMAS, PhD, FIPEM, 1,4KARL HARRISON, MSc, 1,3MARINA ROMANCHIKOVA, PhD, 1,5MICHAEL P F SUTCLIFFE, PhD, MIMechE, 1,6JULIA R FORMAN, PhD, 1,2AMY M BATES, MSc, 1,2RAJ JENA, MD, FRCR, 1,4M ANDREW PARKER, MA(Oxon), PhD and 1,2NEIL G BURNET, MD, FRCR Cancer Research UK VoxTox Research Group, Department of Oncology, University of Cambridge, Addenbrooke’s Hosp...